Quinoline derivatives as phosphodiesterase inhibitors

Details Quinoline derivatives as phosphodiesterase inhibitors Quinoline derivatives as phosphodiesterase inhibitors

2006-02-08

2009-08-11

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S160000, C546S162000, C514S313000

Reexamination Certificate

active

07572915

ABSTRACT:
There are provided according to the invention novel compounds of formula (I)or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20, and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.

REFERENCES:
patent: 5215999 (1993-06-01), Uchida et al.
patent: 0480052 (1992-04-01), None
patent: 0498723 (1992-08-01), None
patent: 03/005355 (2003-01-01), None
patent: 91/14677 (1991-03-01), None
patent: 95/11592 (1995-05-01), None
patent: 98/02434 (1998-01-01), None
patent: 98/13350 (1998-04-01), None
patent: WO 98/57936 (1998-12-01), None
patent: 00/12497 (2000-03-01), None
patent: 00/18740 (2000-04-01), None
patent: 00/18761 (2000-04-01), None
patent: 02/08224 (2002-01-01), None
patent: WO 02/20489 (2002-03-01), None
patent: 0226713 (2002-04-01), None
patent: 02/36570 (2002-05-01), None
patent: 02/44166 (2002-06-01), None
patent: 02/094203 (2002-11-01), None
patent: WO 02/092571 (2002-11-01), None
patent: 02/102315 (2002-12-01), None
patent: 03/035621 (2003-05-01), None
patent: 03/045920 (2003-06-01), None
patent: 03/048152 (2003-06-01), None
patent: 03/064431 (2003-08-01), None
patent: 03/082827 (2003-10-01), None
patent: 04/000828 (2003-12-01), None
patent: 2004/067513 (2004-08-01), None
patent: 2004/080463 (2004-09-01), None
Joshua O Odingo; Inhibitors of PDE4: a review of recent patent literature; Expert Opin Ther. Patents; 2005; 15(7); 773-787; Ashley Publications.

Affiliated with

Also associated with

Rating

Quinoline derivatives as phosphodiesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline derivatives as phosphodiesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as phosphodiesterase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4132436